Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

Market Cap	13.69B +86.3%
Revenue (ttm)	909.54M +38.2%
Net Income	51.08M
EPS	0.13
Shares Out	442.94M
PE Ratio	246.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,666,957
Average Volume	8,462,084
Open	30.42
Previous Close	30.90
Day's Range	30.03 - 31.00
52-Week Range	14.86 - 44.99
Beta	0.79
RSI	44.88
Earnings Date	Mar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 973
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688321